ArticleAnnals of African medicine2026
Enhanced Recovery and Biological Evaluation of Steviol Glycosides from Genotypically Diverse Stevia Rebaudiana.
Article in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSteviol glycosides (SGs) from Stevia rebaudiana are known for their natural sweetness and potential health benefits. However, extraction efficiency and biological activity vary across genotypes and depend on the extraction conditions. AIMS AND
objectivesThis study aimed to evaluate the effect of an optimized extraction method on yield, total polyphenol content, and the in vitro antioxidant and anti-inflammatory activities of steviol glycosides obtained from six S. rebaudiana genotypes. MATERIALS AND
methodsSteviol glycosides were extracted using an optimized protocol. Extraction yield was quantified, and total polyphenol content was determined by the Folin-Ciocalteu method. Antioxidant activity was evaluated by the 2,2 diphenyl 1 picrylhydrazyl (DPPH) radical scavenging and reducing power assays, while anti-inflammatory potential was assessed by the protein denaturation inhibition method. Gallic acid, ascorbic acid and diclofenac sodium served as reference compounds.
resultsThe optimized method significantly enhanced extraction efficiency, reaching 149.00 ± 1.76 mg/g and 142.20 ± 1.62 mg/g for genotypes P7 and V9 7/7, respectively. Genotypes P7, V9, and P7 7/7 exhibited the highest total polyphenol content (0.1 mg/mL). The most potent antioxidant activity was recorded for P7 7/7 and Q1 (DPPH IC 50 = 0.11 mg/mL), comparable to ascorbic acid (0.10 mg/mL). These genotypes also demonstrated the strongest anti-inflammatory activity (IC 50 = 53.77 and 66.06 µg/mL), close to diclofenac sodium (66.02 µg/mL).
conclusionThe optimized extraction process substantially improves the yield and bioactivity of Stevia -derived compounds. Genotype P7 is notable for its high yield and polyphenol content, while P7 7/7 and Q1 show superior antioxidant and anti-inflammatory potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.